Hints and tips:
Related Topics
...Merger and acquisition activity has also buoyed valuations, with $10bn-plus deals announced between Allergan and Actavis, Covidien and Medtronic, Hospira and Pfizer as well as CareFusion and Becton Dickinson...
...The group had planned to use overseas cash belonging to itself and Covidien to help pay for the deal....
...Medtronic of the US last month completed its near-$50bn takeover of Ireland-based Covidien and Zimmer last year bought Biomet for $13.4bn....
...Bankers say that, after huge deals such as Acatvis’s $66bn acquisition of Allergan and the $42.9bn takeover of Medtronic by Covidien in 2014, activity this year is more concentrated around mid-sized deals...
...The above is a clause from the Medtronic/Covidien merger agreement of course – although it allows Medtronic to walk away from the deal if US tax law prevents the company ‘inverting’ to Covidien’s Irish domicile...
...As of Friday’s close, Covidien had a market capitalisation of $32.5bn. It became a publicly traded company in 2007 after it was spun off from Tyco International....
...José Almeida, Covidien’s chief executive, told the FT he would step down once the deal is completed. Medtronic was advised by Perella Weinberg while Covidien was advised by Goldman Sachs....
...Medtronic, a medical device maker, has pressed ahead with its $42.9bn acquisition of rival Covidien in a deal that will give it a tax-efficient Irish address....
...Medtronic, which has struck a $42.9bn deal to buy Ireland-based Covidien, has $13bn of cash outside the US....
...Collapse of the Salix acquisition will raise fresh questions over the fate of other pending inversions, such as the $42.9bn acquisition of Dublin-based Covidien by Medtronic, the US medical devices company...
...Shares in Medtronic, the medical device maker, fell 1.1 per cent to $60.03 after it agreed to buy Dublin-based Covidien Plc for $42.9bn. Shares in Covidien were up 20 per cent to $86.75....
...If completed, its acquisition of Covidien, a maker of devices used in surgical procedures, would create a close rival to Johnson & Johnson, the market leader....
...(Bloomberg) Medtronic snaps up Covidien for $42.9bn: Medtronic, the medical device and equipment maker, has agreed to acquire Irish rival Covidien’s equity in a $42.9bn cash and stock deal that will allow...
...In inversion deals in the past month, Medtronic announced the $42.9bn acquisition of Dublin-based Covidien and AbbVie agreed to take over the UK’s Shire for $54bn....
...Covidien of Ireland, which is being bought by Medtronic, shed 4.26 per cent in early New York trading, while AstraZeneca, the UK pharmaceuticals group that was subject to an abortive offer from Pfizer, closed...
...announced since the start of 2013, according to Dealogic, including Burger King’s $11.4bn acquisition of the Canadian coffee shop chain Tim Hortons last month, and the $42.9bn takeover of Dublin-based Covidien...
...Stryker of the US last month confirmed it had been evaluating a bid for the company but decided against a near-term offer, while Medtronic’s $42.9bn offer for Ireland’s Covidien was seen as taking out a...
...Given Imaging will add $40m to $50m to quarterly revenues in Covidien’s medical devices segment, which had sales of $2.1bn last quarter, and expand its presence in the gastrointestinal market where Covidien...
...this year, with many of the largest transactions initiated by US companies seeking to deploy trapped offshore cash: notably Pfizer’s failed $116bn bid for AstraZeneca, the $43bn purchase of Dublin-based Covidien...
...Others to have struck similar deals this year include Medtronic, the US medical device maker, which agreed last month to buy Dublin-based Covidien for $42.9bn....
...That structure is also a feature of Medtronic’s deal for Covidien. A reason to check the rules – and then to ask whether this structure is a fair division of the inversion spoils....
...Smith & Nephew, the medical devices maker which was considered as a bid target by Stryker before the US company favoured a merger with Ireland’s Covidien, rose 1.7 per cent to £10.83....
...There’s no general walkaway like the one Medtronic got from Covidien over its inversion, for example. Which would sound like Shire’s shareholders come out best here…...
...The proposed deal would surpass last month’s $42.9bn takeover of Dublin-based Covidien by Medtronic, the US medical device maker, as the biggest tax inversion in the healthcare sector so far....
International Edition